Vericel (NASDAQ:VCEL) Stock, Unusual Options

Vericel

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Stock Report

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Comments

Vericel Unusual Options